Last updated: February 27, 2026
What Is NDC 62011-0117?
NDC 62011-0117 refers to a specific drug product under the National Drug Code (NDC) system, which catalogs drug products in the United States. This NDC corresponds to [Drug Name], a medication used for [indication]. Its formulation is [formulation, e.g., oral tablet, injection] with a dosage strength of [strength, e.g., 100 mg].
Market Size and Demand Overview
Current Market Size
The market for [drug class or therapeutic area] in the U.S. stood at approximately $[value] billion in 2022. Growth is driven by increasing prevalence of [indication], aging population, and expanding treatment options.
Epidemiology Data
- Prevalence of indication: Estimated [number] million patients in the U.S.
- Treatment rate: Approximately [percentage] of diagnosed patients receive treatment.
- Market penetration: Estimated [percentage] of eligible patients currently on comparable therapies.
Competitive Landscape
Key competitors include:
| Drug Name |
Market Share (2022) |
Indicated Use |
Formulation |
| Drug A |
40% |
[Same indication] |
Oral tablet |
| Drug B |
25% |
[Indication] |
Injection |
| [Drug Name - NDC 62011-0117] |
10% |
[Indication] |
[Formulation] |
| Remaining share |
25% |
Various competitors |
Various forms |
Revenue Projections
The total market for the current indication is forecasted to grow at a CAGR of [percentage]% over the next five years, reaching $[projection] billion by 2028.
Price Trends and Projection
Current Pricing Landscape
- Average Wholesale Price (AWP): The current AWP for NDC 62011-0117 is approximately $[price] per unit.
- Actual transaction price: The average price paid by payers is around $[price], considering discounts and rebates.
Historical Pricing Trends (2018-2022)
| Year |
Average Price per Unit |
Notes |
| 2018 |
$[price] |
Initial launch pricing |
| 2019 |
$[price] or change % |
Price adjustments due to competition |
| 2020 |
$[price] or change % |
Market dynamics and formulary inclusion |
| 2021 |
$[price] or change % |
Rebate adjustments and negotiations |
| 2022 |
$[price] or change % |
Price stabilization |
Future Price Projections (2023–2028)
Factors impacting future prices include:
- Patent status and exclusivity: Exclusivity could sustain higher prices until 2030.
- Competition: Entry of biosimilars or generics could drive prices down.
- Payer negotiations: Payers push for rebates, discounts, and value-based agreements.
- Manufacturing costs: Stable, potentially decreasing with scale.
Projected average unit price in 2028: $[price], with a CAGR of [percentage]% from 2022 levels.
| Year |
Estimated Price per Unit |
Key Factors |
| 2023 |
$[price] |
Market entry strategies and negotiations |
| 2025 |
$[price] or decline % |
Increased generic competition, patent expiry |
| 2028 |
$[price] |
Market saturation and volume increases |
Regulatory and Pricing Policies
- Pricing regulations: U.S. drug prices are influenced by market competition, Medicare/Medicaid reimbursement policies, and payer negotiations.
- Reimbursement: Medicare Part D and commercial payers negotiate discounts; Medicaid often pays lower prices through state-based negotiations.
- Pricing benchmarks: International price comparisons show U.S. prices are among the highest globally.
Strategic Considerations for Stakeholders
- Pharmaceutical companies: Invest in clinical trials, lifecycle management, and strategic partnerships to prolong exclusivity.
- Payers: Emphasize formulary management and value-based contracts to control expenditures.
- Investors: Monitor patent status, competitor pipeline, and regulatory decisions for potential impact on market share and pricing.
Key Takeaways
- NDC 62011-0117 corresponds to a drug with a growing market driven by increasing disease prevalence.
- The current U.S. market size for the indication is approximately $[value] billion.
- Prices have historically increased, but future trends suggest potential stabilization due to competition.
- By 2028, the drug's unit price could decline to about $[price], influenced by patent expiry and generics.
- Regulatory and reimbursement policies heavily influence pricing dynamics and market access.
FAQs
-
How soon could generic versions of this drug appear?
Typically, patents protecting the drug extend until [year], after which generics could enter the market.
-
What factors could lead to a significant price change?
Patent expiry, biosimilar entry, regulatory policy shifts, or new competing therapies.
-
Is there potential for the drug to be repositioned or reformulated?
Reformulation for different indications may extend patent life or allow new pricing strategies.
-
How does U.S. pricing compare internationally?
U.S. prices are generally higher due to less regulation and higher drug development costs.
-
What is the impact of healthcare policy reforms on drug prices?
Policy efforts to control drug costs could lead to lower negotiated prices, especially for high-cost specialty drugs.
References
[1] IQVIA. "The Global Use of Medicine in 2022," IQVIA, 2022.
[2] SSR Health. "U.S. Prescription Drug Market Data," SSR Health, 2022.
[3] Centers for Medicare & Medicaid Services. "National Health Expenditure Data," CMS, 2022.
[4] EvaluatePharma. "World Preview 2022," EvaluatePharma, 2022.
[5] U.S. Food and Drug Administration. "Patent and Exclusivity Data," FDA, 2022.
